在PI3K/Akt路径的PIMREG调节增强了Huh7细胞中的索拉芬尼抗性
Lei Zhang1, Aijun Gao1, Kaiyun Peng2
1Department of Medical Laboratory Technology, Medical College, Yangzhou Polytechnic College, Yangzhou 225009, China.
概括
与线粒调节因子 (PIMREG) 相互作用的酸氨基醇结合性网红素组合蛋白驱动肝细胞癌 (HCC) 中的索拉芬尼抗性. 向PIMREG通过抑制PI3K/AKT通路来增强索拉芬尼的疗效,为HCC治疗提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 索拉菲尼布是一种多向的口服化疗剂,用于抑制癌症生长.
- 与线粒调节因子 (PIMREG) 相互作用的酸氨基醇结合性网球蛋白组合蛋白与癌症药物耐药性有关.
- 皮姆雷格在肝细胞癌 (HCC) 中索拉芬尼抗性的确切作用和调控机制在很大程度上仍未确定.
研究的目的:
- 调查PIMREG在HCC中调解索拉费尼布耐药性的作用.
- 阐明 PIMREG 影响 HCC 细胞对索拉费尼布治疗反应的分子机制.
- 探索PIMREG作为一种潜在的治疗点,以克服HCC中索拉芬尼抗性.
主要方法:
- 使用了人类HCC细胞系 (Huh7和Huh7/SFB) 具有不同的索拉芬尼敏感性.
- 在HCC细胞中操纵PIMREG表达 (过度表达和干扰) 并用sorafenib治疗.
- 通过使用MTT,qRT-PCR,流细胞计和西斑检测,评估细胞活力,IC50值,增殖和亡.
- 进行了体内小鼠研究,并使用PI3K/AKT通路抑制剂 (LY294002) 来探索机制.
主要成果:
- 与敏感细胞 (Huh7) 相比,PIMREG表达在抗索拉芬尼布的HCC细胞 (Huh7/SFB) 中显著更高.
- PIMREG干扰降低了IC50值并增强了索拉费尼布的抗增殖作用,而PIMREG过度表达则产生了相反的效果.
- 在体内,PIMREG淘汰赛改善了索拉费尼布的疗效.
- 确定PI3K/AKT信号通路对于PIMREG介导的索拉芬尼抗性至关重要,PIMREG调节这种通路.
结论:
- 提升的PIMREG表达赋予HCC中对索拉费尼布的耐药性.
- 皮姆雷格通过PI3K/AKT信号通路调解索拉芬尼抗性.
- 皮姆雷格代表了一个重要的瘤相关基因,也是提高HCC索拉费尼布疗效的潜在治疗标.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K